208 related articles for article (PubMed ID: 20098570)
1. The art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure.
Walker JR; Singal PK; Jassal DS
Exp Clin Cardiol; 2009; 14(3):e62-7. PubMed ID: 20098570
[TBL] [Abstract][Full Text] [Related]
2. Trastuzumab-induced cardiac dysfunction: A 'dual-hit'.
Zeglinski M; Ludke A; Jassal DS; Singal PK
Exp Clin Cardiol; 2011; 16(3):70-4. PubMed ID: 22065936
[TBL] [Abstract][Full Text] [Related]
3. Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2-positive breast cancer.
Pivot X; Pegram M; Cortes J; Lüftner D; Lyman GH; Curigliano G; Bondarenko I; Yoon YC; Kim Y; Kim C
Eur J Cancer; 2019 Oct; 120():1-9. PubMed ID: 31445454
[TBL] [Abstract][Full Text] [Related]
4. The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity.
Akolkar G; Bhullar N; Bews H; Shaikh B; Premecz S; Bordun KA; Cheung DY; Goyal V; Sharma AK; Garber P; Singal PK; Jassal DS
Cardiovasc Ultrasound; 2015 Apr; 13():18. PubMed ID: 25889218
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin and trastuzumab regimen induces biventricular failure in mice.
Milano G; Raucci A; Scopece A; Daniele R; Guerrini U; Sironi L; Cardinale D; Capogrossi MC; Pompilio G
J Am Soc Echocardiogr; 2014 May; 27(5):568-79. PubMed ID: 24534652
[TBL] [Abstract][Full Text] [Related]
6. Preventing broken hearts in women with breast cancer: a concise review on chemotherapy-mediated cardiotoxicity.
Bews HJ; Mackic L; Jassal DS
Can J Physiol Pharmacol; 2023 Dec; ():. PubMed ID: 38039515
[TBL] [Abstract][Full Text] [Related]
7. Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.
Rygiel K
Indian J Pharmacol; 2016; 48(5):490-497. PubMed ID: 27721532
[TBL] [Abstract][Full Text] [Related]
8. The cardioprotective role of probucol against anthracycline and trastuzumab-mediated cardiotoxicity.
Walker JR; Sharma A; Lytwyn M; Bohonis S; Thliveris J; Singal PK; Jassal DS
J Am Soc Echocardiogr; 2011 Jun; 24(6):699-705. PubMed ID: 21353471
[TBL] [Abstract][Full Text] [Related]
9. Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab.
Altomare C; Lodrini AM; Milano G; Biemmi V; Lazzarini E; Bolis S; Pernigoni N; Torre E; Arici M; Ferrandi M; Barile L; Rocchetti M; Vassalli G
Front Physiol; 2021; 12():658790. PubMed ID: 33897465
[TBL] [Abstract][Full Text] [Related]
10. Catching broken hearts: pre-clinical detection of doxorubicin and trastuzumab mediated cardiac dysfunction in the breast cancer setting.
Saeed MF; Premecz S; Goyal V; Singal PK; Jassal DS
Can J Physiol Pharmacol; 2014 Jul; 92(7):546-50. PubMed ID: 24959994
[TBL] [Abstract][Full Text] [Related]
11. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
Slamon DJ; Leyland-Jones B; Shak S; Fuchs H; Paton V; Bajamonde A; Fleming T; Eiermann W; Wolter J; Pegram M; Baselga J; Norton L
N Engl J Med; 2001 Mar; 344(11):783-92. PubMed ID: 11248153
[TBL] [Abstract][Full Text] [Related]
12. A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results.
Pivot X; Bondarenko I; Nowecki Z; Dvorkin M; Trishkina E; Ahn JH; Im SA; Sarosiek T; Chatterjee S; Wojtukiewicz MZ; Shparyk Y; Moiseyenko V; Bello M; Semiglazov V; Lee Y; Lim J
Eur J Cancer; 2018 Apr; 93():19-27. PubMed ID: 29448072
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholine receptor agonists effectively attenuated multiple program cell death pathways and improved left ventricular function in trastuzumab-induced cardiotoxicity in rats.
Prathumsap N; Ongnok B; Khuanjing T; Arinno A; Maneechote C; Chunchai T; Arunsak B; Kerdphoo S; Chattipakorn SC; Chattipakorn N
Life Sci; 2023 Sep; 329():121971. PubMed ID: 37482212
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial.
Pivot X; Cortés J; Lüftner D; Lyman GH; Curigliano G; Bondarenko IM; Ahn JH; Im SA; Litwiniuk M; Shparyk YV; Ho GF; Kislov NV; Wojtukiewicz M; Sarosiek T; Chae YS; Ahn JS; Jang H; Kim S; Lee J; Yoon Y
JAMA Netw Open; 2023 Apr; 6(4):e235822. PubMed ID: 37022687
[TBL] [Abstract][Full Text] [Related]
15. Trastuzumab aggravates radiation induced cardiotoxicity in mice.
Yi P; Li H; Su J; Cai J; Xu C; Chen J; Cao L; Li M
Am J Cancer Res; 2022; 12(1):381-395. PubMed ID: 35141025
[TBL] [Abstract][Full Text] [Related]
16. Vagus nerve stimulation and acetylcholinesterase inhibitor donepezil provide cardioprotection against trastuzumab-induced cardiotoxicity in rats by attenuating mitochondrial dysfunction.
Khuanjing T; Maneechote C; Ongnok B; Prathumsap N; Arinno A; Chunchai T; Arunsak B; Chattipakorn SC; Chattipakorn N
Biochem Pharmacol; 2023 Nov; 217():115836. PubMed ID: 37816466
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway.
Ebrahim N; Al Saihati HA; Mostafa O; Hassouna A; Abdulsamea S; Abd El Aziz M El Gebaly E; Abo-Rayah NH; Sabry D; El-Sherbiny M; Madboly AG; Hussien NI; Saadani REH; Ebrahim HA; Badr OAM; Elsherbiny NM; Salim RF
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682646
[TBL] [Abstract][Full Text] [Related]
18. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity.
Milano G; Biemmi V; Lazzarini E; Balbi C; Ciullo A; Bolis S; Ameri P; Di Silvestre D; Mauri P; Barile L; Vassalli G
Cardiovasc Res; 2020 Feb; 116(2):383-392. PubMed ID: 31098627
[TBL] [Abstract][Full Text] [Related]
19. The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice.
Asselin CY; Lam A; Cheung DYC; Eekhoudt CR; Zhu A; Mittal I; Mayba A; Solati Z; Edel A; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Pierce GN; Niraula S; Jassal DS
J Nutr; 2020 Sep; 150(9):2353-2363. PubMed ID: 32510147
[TBL] [Abstract][Full Text] [Related]
20. Cardiac tolerability of concurrent administration of trastuzumab and anthracycline-based regimen as adjuvant chemotherapy for breast cancer.
Watanabe N; Otsuka S; Sasaki Y; Shimojima R; Wani Y; Uchino K
Breast Care (Basel); 2014 Feb; 9(1):46-51. PubMed ID: 24803887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
